44 min listen
Stocks like Skinny, Eli Lilly’s Big FDA Move, & a Real Threat to Tech Titans?
FromThe Exchange
ratings:
Length:
45 minutes
Released:
Oct 7, 2020
Format:
Podcast episode
Description
Stocks are rallying as the President proposes smaller, targeted relief aid but do investors believe this is real progress? We debate.Plus, Eli Lilly has filed for FDA emergency use authorization of its Covid-19 antibody drug. We’ll speak with the CEO about the treatment, the potential timeline, and what production could look like.And, in its lengthy report, Congress concludes four big tech giants have monopoly power and it’s time for changes. We look at what is likely to make its way into the bills as the real work begins.
Released:
Oct 7, 2020
Format:
Podcast episode
More Episodes from The Exchange
Rate debate, un-welcoming party?, and Credit Suisse bets on bubbles: We’re just an hour away from getting the minutes from the latest Fed meeting, where the FOMC started to sound hawkish. We’ll debate which way rates go next. Plus, Chinese stocks are selling off again today. Did U.S. investors overestimate how committed China was to capitalism? We’ll explore how ‘welcoming’ (or not) it’s becoming to outside investors. And, in today’s Rapid Fire: more people are paying with crypto, some people are working less but getting paid the same, and Credit Suisse is betting more people will begin drinking hard seltzer. by The Exchange